🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Eric Bartee

University of New Mexico

ORCID: 0000-0003-1793-446X

Also affiliated with New Mexico Cancer Center, UNM Comprehensive Cancer Center

Biochemistry, Genetics and Molecular BiologyMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Defects in intratumoral arginine metabolism attenuate the replication and therapeutic efficacy of oncolytic myxoma virus”.

Defects in intratumoral arginine metabolism attenuate the replication and therapeutic efficacy of oncolytic myxoma virus

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2022-006388

N/A

0.345DataRank · unranked

9 citations

Heather D. Curtsinger, Mee Y. Bartee, Eric Bartee, Parker Dryja

Initial dose of oncolytic myxoma virus programs durable antitumor immunity independent of in vivo viral replication

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-000804

N/A

0DataRank · unranked

8 citations

Bülent Arman Aksoy, Eric Bartee, Erica Flores

Decreasing the Susceptibility of Malignant Cells to Infection Does Not Impact the Overall Efficacy of Myxoma Virus-Based Oncolytic Virotherapy

Molecular Therapy — Oncolytics(2020)10.1016/j.omto.2020.10.011

N/A

0DataRank · unranked

3 citations

Eric Bartee, Erica Flores

B cells imprint adoptively transferred CD8 + T cells with enhanced tumor immunity

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.03.16.435714

N/A

0DataRank · unranked

0 citations

Hannah M. Knochelmann, Megan M. Wyatt, Guillermo O. Rangel Rivera, Amalia M Rivera-Reyes, Connor J. Dwyer +7 more

The use of oncolytic virotherapy in the neoadjuvant setting

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-004462

N/A

0DataRank · unranked

26 citations

Eric Bartee, Raquela J. Thomas

B cells imprint adoptively transferred CD8 + T cells with enhanced tumor immunity

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-003078

N/A

0DataRank · unranked

16 citations

Hannah M. Knochelmann, Megan M. Wyatt, Guillermo O. Rangel Rivera, Amalia M Rivera-Reyes, Connor J. Dwyer +9 more

Monitoring Therapeutic Responses to Silicified Cancer Cell Immunotherapy Using PET/MRI in a Mouse Model of Disseminated Ovarian Cancer

International Journal of Molecular Sciences(2022)10.3390/ijms231810525

N/A

0DataRank · unranked

6 citations

Colin M. Wilson, Stefan Franco, Henning De May, Lorél Y. Medina, Yirong Yang +5 more

Saturated fatty acids dampen the immunogenicity of cancer by suppressing STING

Cell Reports(2023)10.1016/j.celrep.2023.112303

N/A

0DataRank · unranked

32 citations

Wang Gong, Hülya F. Taner, Luke J. Broses, Kohei Okuyama, Wanqing Cheng +12 more

Oncolytic myxoma virus is effective in murine models of triple negative breast cancer despite poor rates of infection

Molecular Therapy — Oncolytics(2023)10.1016/j.omto.2023.08.014

N/A

0DataRank · unranked

7 citations

Mee Y. Bartee, Miriam Valenzuela-Cardenas, Eric Bartee, Raquela J. Thomas

1218 Selective internalization of microbial mimetic mesoporous silica nanoparticles by myeloid-derived suppressor cells with trafficking to tumor-burdened tissues in a mouse model of ovarian cancer

Regular and Young Investigator Award Abstracts(2023)10.1136/jitc-2023-sitc2023.1218

N/A

0DataRank · unranked

0 citations

Erica Flores, John P. O’Rourke, Eric Bartee, Achraf Noureddine, Rita E. Serda +1 more

TLR Agonist Nano Immune Therapy Clears Peritoneal and Systemic Ovarian Cancer

Advanced Healthcare Materials(2024)10.1002/adhm.202402966

N/A

0DataRank · unranked

11 citations

Henning De May, Lauren G. Anderson, Lorél Y. Medina, Erin B. Kennedy, Erica Flores +11 more

IL-12-mediated toxicity from localized oncolytic virotherapy can be reduced using systemic TNF blockade

Molecular Therapy Oncology(2024)10.1016/j.omton.2024.200866

N/A

0DataRank · unranked

4 citations

Carrie Fisher, Mee Y. Bartee, Eric Bartee, Miriam Valenzuela-Cardenas

Regional immune mechanisms enhance efficacy of an autologous cellular cancer vaccine with intraperitoneal administration

OncoImmunology(2024)10.1080/2162402x.2024.2421029

N/A

0DataRank · unranked

1 citations

Lorél Y. Medina, Henning De May, Joshua E. Adogla, Erin B. Kennedy, Erica Flores +5 more

Navigating a complex dance: the interplay between RNA-binding proteins and T cells in oral epithelial plasticity

Immunometabolism(2025)10.1097/in9.0000000000000054

N/A

0DataRank · unranked

0 citations

Sekar Vasudevan, Samu John, Michelle A. Ozbun, Eric Bartee, Viswanathan Palanisamy +1 more

Myeloid-derived suppressor cells inhibit the replication of oncolytic virus by reducing intratumoral arginine levels

Molecular Therapy Oncology(2025)10.1016/j.omton.2025.201066

N/A

0DataRank · unranked

0 citations

Erica Flores, Mee Y. Bartee, Viswanathan Palanisamy, Eric Bartee, Parker Dryja

Reduced cellular binding affinity has profoundly different impacts on the spread of distinct poxviruses

PLoS ONE(2020)10.1371/journal.pone.0231977

N/A

0DataRank · unranked

8 citations

Mee Y. Bartee, Eric Bartee, Erica Flores

The potential for p53 reactivators to increase the sensitivity of aggressive gynecologic cancers to immunotherapy 3272

The Journal of Immunology(2025)10.1093/jimmun/vkaf283.1090

N/A

0DataRank · unranked

0 citations

Jamie L. Padilla, Geneva L. Williams, Daisy Belmares-Ortega, Xiangxiang Wu, Eric Bartee +2 more